Cargando…
What can we learn from the recent blood glucose lowering megatrials?
In the past two decades, we have acquired an enormous amount of knowledge regarding the epidemiology, diagnosis, pathophysiology and treatment of type 2 diabetes and its comorbidities. In addition to the earlier landmark blood lipid and blood pressure lowering trials, the latest blood glucose loweri...
Autor principal: | Chan, Juliana CN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008009/ https://www.ncbi.nlm.nih.gov/pubmed/24843455 http://dx.doi.org/10.1111/j.2040-1124.2010.00063.x |
Ejemplares similares
-
Fundamental deficiencies in the megatrial methodology
por: Charlton, Bruce G
Publicado: (2001) -
Are there fundamental deficiencies in the megatrial methodology?
por: Julian, Desmond, et al.
Publicado: (2001) -
What we can learn on inflation from recent CMBR data
por: Covi, L
Publicado: (2001) -
Depression pathogenesis and treatment: what can we learn from blood mRNA expression?
por: Hepgul, Nilay, et al.
Publicado: (2013) -
The Genetics of Diabetes: What We Can Learn from Drosophila
por: Liguori, Francesco, et al.
Publicado: (2021)